← All trials
NCT06257316
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 15, 2024
- Primary completion
- Feb 28, 2027
- Completion date
- Feb 28, 2028
- First posted
- Feb 13, 2024
- Last posted
- Feb 15, 2024
- Enrollment
- 132
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Seoul National UniversityLead sponsor
- Seoul National UniversityOfficial
- Seoul National UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.